Evidence map›Paper›PMID 40156415›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2025

Designing and Implementing a Cancer Screening Program for Underserved Tribal Women in Jharkhand.

Rahul Rewati Raman, Somika Meet, Hemlata M Tiwari, Kunal Oswal, Neetu Sinha, Amol Gaikwad, Yogesh Jain, Umesh Rana, Ramachandran Venkataramanan, Rengaswamy Sankaranarayanan

Abstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rahul Rewati RamanScreening and Early Detection, Karkinos Healthcare, Ranchi, Jharkhand, India.
Somika MeetScreening and Early Detection, Karkinos Healthcare, Ranchi, Jharkhand, India.
Hemlata M TiwariScreening and Early Detection, Karkinos Healthcare, Mumbai, Maharashtra, India.
Kunal OswalScreening and Early Detection, Karkinos Healthcare, Mumbai, Maharashtra, India.ORCID 0000-0003-4467-2274
Neetu SinhaScreening and Early Detection, Karkinos Healthcare, Ranchi, Jharkhand, India.
Amol GaikwadNon-Communicable Disease, Karkinos Healthcare, Pune, Maharashtra, India.
Yogesh JainDirector, Non-communicable Diseases, Karkinos Healthcare, Bilaspur, Chhattisgarh, India.
Umesh RanaHealth, Collectives for Integrated Livelihood Initiatives, Ranchi, Jharkhand, India.
Ramachandran VenkataramananCEO, Karkinos Healthcare, Mumbai, Maharashtra, India.ORCID 0000-0001-5204-3748
Rengaswamy SankaranarayananDirector, Preventive Oncology, Karkinos Healthcare, Chennai, Tamil Nadu, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe status of cancer screening in India is concerning, especially in tribal states like Jharkhand, where the percentage of women who have ever undergone screening for cervical, breast, and oral cancer is 0.5, 0.1, and 0.2 percent, respectively. Adopting the community-led approach, Karkinos Healthcare, a purpose driven oncology platform, conducted a cancer screening program in collaboration with a livelihood-focused NGO in selected districts of Jharkhand. This study aims to describe the program's implementation and assess the program's performance vis a vis provision of care continuum from screening to treatment.

methodsThe program was designed to provide comprehensive services including cancer awareness, enrolment for specialized cancer insurance for one year to cover the cost of treatment, risk assessment, screening for oral, breast, and cervical cancers, diagnostics to screen positive cases, and treatment to the confirmed cancer cases.

resultsA total of 16875 women underwent risk assessments, all of whom were invited for screening at community clinics. A total of 5993 women (34.9%) reported at community clinics and 5873 (34.9%), 5843 (34.7%), and 5029 (29.9%) underwent screening for oral, breast, and cervical cancer. 70% of the total HPV-positive cases had high-risk types other than HPV 16 and 18. 22.4% of the total screened women were navigated for advanced diagnostics and treatment among which 6 confirmed cases of cancer were reported.

conclusionWhile the program design tried to address the implementation challenges like fragmented care, accessibility, and affordability of cancer care services, conversion from screening to treatment was limited.

Indexed as

Breast NeoplasmsEarly Detection of CancerMass ScreeningNeoplasmsUterine Cervical NeoplasmsAdultFemaleFollow-Up StudiesHumansIndiaMiddle AgedPrognosisbreast cancerCervical canceroral cancerTribes

Identifiers

PMID40156415
PMCPMC12174519

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.